Literature DB >> 14741037

2D QSAR consensus prediction for high-throughput virtual screening. An application to COX-2 inhibition modeling and screening of the NCI database.

Nicolas Baurin1, Jean-Christophe Mozziconacci, Eric Arnoult, Philippe Chavatte, Christophe Marot, Luc Morin-Allory.   

Abstract

Using classification (SOM, LVQ, Binary, Decision Tree) and regression algorithms (PLS, BRANN, k-NN, Linear), this paper details the building of eight 2D-QSAR models from a 266 COX-2 inhibitor training set. The predictive performances of these eight models were subsequently compared using an 88 COX-2 inhibitor test set. Each ligand is described by 52 2D descriptors expressed as van der Waals Surface Areas (P_VSA) and its COX-2 binding IC50. One of our best predictive models is the neural network model (BRANN), which is able to select a subset, from the 88 ligand test set, that contains 94% COX-2 active inhibitors (pIC50>7.5) and detects 71% of all the actives. We then introduce a QSAR consensus prediction protocol that is shown to be more predictive than any single QSAR model: our C3 consensus approach is able to select a subset from the 88 ligand test set that contains 94% active inhibitors and 83% of all the actives. The 2D QSAR consensus protocol was finally applied to the high-throughput virtual screening of the NCI database, containing 193,477 organic compounds.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14741037     DOI: 10.1021/ci0341565

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  14 in total

1.  Discovery of new Mycobacterium tuberculosis proteasome inhibitors using a knowledge-based computational screening approach.

Authors:  Rukmankesh Mehra; Reena Chib; Gurunadham Munagala; Kushalava Reddy Yempalla; Inshad Ali Khan; Parvinder Pal Singh; Farrah Gul Khan; Amit Nargotra
Journal:  Mol Divers       Date:  2015-08-01       Impact factor: 2.943

2.  Why relevant chemical information cannot be exchanged without disclosing structures.

Authors:  Dmitry Filimonov; Vladimir Poroikov
Journal:  J Comput Aided Mol Des       Date:  2005-11-03       Impact factor: 3.686

3.  Reverse fingerprinting, similarity searching by group fusion and fingerprint bit importance.

Authors:  Chris Williams
Journal:  Mol Divers       Date:  2006-09-21       Impact factor: 2.943

4.  Generation of in-silico cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A4 inhibition QSAR models.

Authors:  M Paul Gleeson; Andrew M Davis; Kamaldeep K Chohan; Stuart W Paine; Scott Boyer; Claire L Gavaghan; Catrin Hasselgren Arnby; Cecilia Kankkonen; Nan Albertson
Journal:  J Comput Aided Mol Des       Date:  2007-11-22       Impact factor: 3.686

5.  A ligand's-eye view of protein binding.

Authors:  Robert D Clark
Journal:  J Comput Aided Mol Des       Date:  2008-01-24       Impact factor: 3.686

6.  Hierarchical QSAR technology based on the Simplex representation of molecular structure.

Authors:  V E Kuz'min; A G Artemenko; E N Muratov
Journal:  J Comput Aided Mol Des       Date:  2008-02-06       Impact factor: 3.686

7.  Modeling the binding modes of stilbene analogs to cyclooxygenase-2: a molecular docking study.

Authors:  Souhila Bouaziz-Terrachet; Amel Toumi-Maouche; Boubekeur Maouche; Safia Taïri-Kellou
Journal:  J Mol Model       Date:  2010-03-17       Impact factor: 1.810

Review 8.  Considerations and recent advances in QSAR models for cytochrome P450-mediated drug metabolism prediction.

Authors:  Haiyan Li; Jin Sun; Xiaowen Fan; Xiaofan Sui; Lan Zhang; Yongjun Wang; Zhonggui He
Journal:  J Comput Aided Mol Des       Date:  2008-06-24       Impact factor: 3.686

9.  A novel hybrid ultrafast shape descriptor method for use in virtual screening.

Authors:  Edward O Cannon; Florian Nigsch; John B O Mitchell
Journal:  Chem Cent J       Date:  2008-02-18       Impact factor: 4.215

10.  A QSTR-Based Expert System to Predict Sweetness of Molecules.

Authors:  Cristian Rojas; Roberto Todeschini; Davide Ballabio; Andrea Mauri; Viviana Consonni; Piercosimo Tripaldi; Francesca Grisoni
Journal:  Front Chem       Date:  2017-07-25       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.